Aprepitant boasted a protective effect against olanzapine-induced metabolic syndrome and its subsequent hepatic, renal, and ovarian dysfunction; Role of IGF1/p-AKT …
RH Mohyeldin, WY Abdelzaher, EE Sharata… - Biochemical …, 2024 - Elsevier
Olanzapine-induced metabolic syndrome (MS) is a primary risk factor for insulin resistance,
hepatorenal damage, and polycystic ovarian syndrome. The objective of the current study …
hepatorenal damage, and polycystic ovarian syndrome. The objective of the current study …
[HTML][HTML] Potential biomarkers and therapeutic targets for obsessive compulsive disorder: Evidences from clinical studies
A Sultania, S Venkatesan, DR Batra, K Rajesh… - Biochemia …, 2024 - hrcak.srce.hr
Obsessive compulsive disorder (OCD) is a prevalent behavioral disorder with a complex
etiology. However, the underlying pathogenic molecular pathways and the associated risk …
etiology. However, the underlying pathogenic molecular pathways and the associated risk …
Case of Medication-Induced Weight Gain and Diabetes
JJ Neumiller - diabetesincontrol.com
A 29-year-old female with a history of schizophrenia and depression was referred for a
pharmacotherapy evaluation by her social work case manager. During a recent visit by the …
pharmacotherapy evaluation by her social work case manager. During a recent visit by the …